dr. voss on phase i/ii trial data of medi0680/durvalumab versus nivolumab in mrcc
Published 4 years ago • 113 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
1:56
exploring medi0680/durvalumab versus nivolumab in metastatic ccrcc
-
2:25
dr. motzer on a phase ii trial of nivolumab for mrcc
-
2:06
dr. choueiri on phase i/ii data of mk-6482 in advanced clear cell rcc
-
4:05
long-term rcc data with nivolumab
-
1:06
dr. voss on the future of clinical trials for kidney cancer
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
3:41
checkmate 9er: phase 3 trial of frontline nivolumab cabozantinib
-
1:01
dr. heymach on nivolumab for lung cancer
-
4:43
nivolumab in renal cell carcinoma
-
6:52
nivolumab in renal cell carcinoma
-
1:22
dr. mcdermott on major findings of efficacy and safety of nivolumab in rcc
-
1:33
dr. mcdermott on single-agent nivolumab in rcc
-
2:10
strong: fixed-dose durvalumab for utc
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
11:42
nivolumab in renal cell carcinoma
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
-
6:37
cabozantinib in combination with nivolumab demonstrated continued survival and hrqol in arcc pat...